Themis Medicare Dirección
Dirección controles de criterios 1/4
El CEO de Themis Medicare's es Sachin Patel , nombrado en Feb 2017, tiene una permanencia de 7.17 años. compensación anual total es ₹21.23M, compuesta por 59.3% salario y 40.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 5.99% de las acciones de la empresa, por valor de ₹1.14B. La antigüedad media del equipo directivo y de la junta directiva es de 6.9 años y 2.4 años, respectivamente.
Información clave
Sachin Patel
Chief Executive Officer (CEO)
₹21.2m
Compensación total
| Porcentaje del salario del CEO | 59.3% |
| Permanencia del CEO | 7.3yrs |
| Participación del CEO | 6.0% |
| Permanencia media de la dirección | 7yrs |
| Promedio de permanencia en la Junta Directiva | 2.5yrs |
Actualizaciones recientes de la dirección
Recent updates
What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You
Dec 27
Themis Medicare (NSE:THEMISMED) Takes On Some Risk With Its Use Of Debt
Dec 01Themis Medicare (NSE:THEMISMED) Has Affirmed Its Dividend Of ₹5.00
Aug 18Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Aug 04Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Jul 18We Think Themis Medicare (NSE:THEMISMED) Is Taking Some Risk With Its Debt
Jul 08Themis Medicare (NSE:THEMISMED) Is Due To Pay A Dividend Of ₹5.00
May 18Themis Medicare (NSE:THEMISMED) Seems To Use Debt Quite Sensibly
Dec 21Themis Medicare (NSE:THEMISMED) Has Announced That It Will Be Increasing Its Dividend To ₹5.00
Aug 28Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹5.00
Aug 08Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
Jul 21Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
May 27Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
May 12Calculating The Fair Value Of Themis Medicare Limited (NSE:THEMISMED)
Nov 09Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
Oct 26Increases to Themis Medicare Limited's (NSE:THEMISMED) CEO Compensation Might Cool off for now
Sep 11Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹4.30
Aug 16Do Themis Medicare's (NSE:THEMISMED) Earnings Warrant Your Attention?
Jul 09Estimating The Intrinsic Value Of Themis Medicare Limited (NSE:THEMISMED)
May 14If You Like EPS Growth Then Check Out Themis Medicare (NSE:THEMISMED) Before It's Too Late
Mar 23These 4 Measures Indicate That Themis Medicare (NSE:THEMISMED) Is Using Debt Reasonably Well
Mar 02Why Themis Medicare Limited (NSE:THEMISMED) Is A Top Dividend Stock
Feb 08Themis Medicare Limited's (NSE:THEMISMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 11
Here's What We Think About Themis Medicare's (NSE:THEMISMED) CEO Pay
Dec 14Does Themis Medicare (NSE:THEMISMED) Have A Healthy Balance Sheet?
Nov 16Are You An Income Investor? Don't Miss Out On Themis Medicare Limited (NSE:THEMISMED)
Oct 21Themis Medicare Limited (NSE:THEMISMED) Looks Interesting, And It's About To Pay A Dividend
Sep 13Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹453m |
| Sep 30 2023 | n/a | n/a | ₹512m |
| Jun 30 2023 | n/a | n/a | ₹577m |
| Mar 31 2023 | ₹21m | ₹13m | ₹569m |
| Dec 31 2022 | n/a | n/a | ₹584m |
| Sep 30 2022 | n/a | n/a | ₹576m |
| Jun 30 2022 | n/a | n/a | ₹591m |
| Mar 31 2022 | ₹13m | ₹7m | ₹729m |
| Dec 31 2021 | n/a | n/a | ₹710m |
| Sep 30 2021 | n/a | n/a | ₹703m |
| Jun 30 2021 | n/a | n/a | ₹591m |
| Mar 31 2021 | ₹7m | ₹7m | ₹357m |
| Dec 31 2020 | n/a | n/a | ₹349m |
| Sep 30 2020 | n/a | n/a | ₹338m |
| Jun 30 2020 | n/a | n/a | ₹274m |
| Mar 31 2020 | ₹7m | ₹7m | ₹248m |
| Dec 31 2019 | n/a | n/a | ₹61m |
| Sep 30 2019 | n/a | n/a | -₹45m |
| Jun 30 2019 | n/a | n/a | -₹64m |
| Mar 31 2019 | ₹7m | ₹7m | -₹107m |
| Dec 31 2018 | n/a | n/a | ₹54m |
| Sep 30 2018 | n/a | n/a | ₹78m |
| Jun 30 2018 | n/a | n/a | ₹101m |
| Mar 31 2018 | ₹6m | ₹6m | ₹113m |
Compensación vs. Mercado: La compensación total de Sachin($USD254.65K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD191.82K).
Compensación vs. Ingresos: La compensación de Sachin ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.
CEO
Sachin Patel (48 yo)
7.3yrs
Permanencia
₹21,231,777
Compensación
Dr. Sachin Dinesh Patel, Ph D., CChem. has been Chief Executive Officer and Managing Director of Themis Medicare Limited since February 14, 2017.He served as Deputy Managing Director at Themis Medicare Lt...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 1.5yrs | ₹21.51m | 10.55% ₹ 2.0b | |
| CEO, MD & Executive Director | 7.3yrs | ₹21.23m | 5.99% ₹ 1.2b | |
| Chief Financial Officer | 7.6yrs | ₹2.27m | sin datos | |
| VP of Systems & Administration and Alternate Non-Executive Non-Independent Director | no data | sin datos | 4.04% ₹ 774.9m | |
| Compliance Officer & Company Secretary | 6.8yrs | ₹1.29m | sin datos |
7.0yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de THEMISMED es experimentado (6.9 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 1.5yrs | ₹21.51m | 10.55% ₹ 2.0b | |
| CEO, MD & Executive Director | 17.3yrs | ₹21.23m | 5.99% ₹ 1.2b | |
| VP of Systems & Administration and Alternate Non-Executive Non-Independent Director | less than a year | sin datos | 4.04% ₹ 774.9m | |
| Non-Executive Director | 17.1yrs | ₹410.00k | 0.079% ₹ 15.1m | |
| Independent Director | 2.5yrs | ₹520.00k | sin datos | |
| Independent Director | less than a year | sin datos | sin datos | |
| Independent Director | 10.3yrs | ₹360.00k | sin datos | |
| Additional Independent Woman Director | 3.5yrs | ₹260.00k | sin datos | |
| Non-Executive Non-Independent Director | less than a year | sin datos | sin datos |
2.5yrs
Permanencia media
67yo
Promedio de edad
Junta con experiencia: La junta directiva de THEMISMED no se considera experimentada (2.4 años de permanencia promedio), lo que sugiere una nueva junta directiva.